aTyr Pharma Class Action Lawsuit: 8 Often Asked Questions

Introduction to the aTyr Pharma Class Action Lawsuit

The aTyr Pharma class action lawsuit seeks to represent purchasers or acquirers of aTyr Pharma Inc. (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”).  Captioned Munguia v. aTyr Pharma Inc., No. 25-cv-02681 (S.D. Cal.), the aTyr Pharma class action lawsuit charges aTyr Pharma and aTyr Pharma’s CEO with violations of th Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the aTyr Pharma class action lawsuit, or just have general questions about you rights as a shareholder, please contact attorney Timothy L. Miles of the Law Offices of Timothy L. Miles, at no cost, by calling 855/846-6529 or via e-mail at [email protected].

Lead plaintiff motions for the aTyr Pharma class action lawsuit must be filed with the court no later than December 8, 2025.

Read on for answers to the eight most frequently asked by investors about the aTyr Pharma class action lawsuit.

When is the Lead Plaintiff Deadline in the aTyr Pharma Class Action Lawsuit?

What Are the Benefits of Serving as a Lead Plaintiff as Serving as Lead Plaintiff in the aTyr Pharma Class Action Lawsuit?

• Influencing litigation strategy: As a lead plaintiff, you have a direct voice in key strategic decisions, including the decision to settle or proceed to trial.

• Negotiating more competitive fees: Your involvement provides an opportunity to negotiate more competitive attorney fees and reduce litigation costs, which can maximize the net recovery for the entire class.

• Active participation in the case: You will be able to review important court filings, monitor the progress of the case, and discuss litigation strategies with legal counsel.

• Leading settlement discussions: Lead plaintiffs participate in mediation and settlement discussions and must approve any settlement before it is presented to the court.

• No financial risk: In most cases, no financial risk, as lead counsel covers all costs and expenses. They work on a contingency basis are only paid if they secure a settlement or judgment, and reimbursement for expenses comes from the settlement fund, not your personal assets.

What Are the Responsibilities the Lead Plaintiff Will Have in the  aTyr Pharma Class Action Lawsuit?

• Overseeing lead counsel: You will select, monitor, and oversee the law firm representing the class.

• Reviewing legal documents: You will review and provide feedback on important court filings before they are submitted.

• Discussing strategy: You will work directly with lead counsel to discuss litigation strategies and key decisions.

• Potential participation in legal events: This may include attending depositions and hearings, if necessary.

• Input on settlement decisions: Your input will be crucial for any decision concerning the settlement of the securities class action.

What Are the The Eligibility Criteria for Lead Plaintiff Appointment in the aTyr Pharma Class Action Lawsuit?

To be eligible for appointment as the lead plaintiff in the aTyr Pharma  Class Action Lawsuit, an investor must meet the following criteria:

• Securities Acquisition: You must have been a  purchasers or acquirer of aTyr Pharma Inc. (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”).

• Financial Losses: The investor must have suffered financial losses as a direct result of the alleged securities fraud perpetrated by aTyr Pharma and its executives.

• Typicality and Adequacy: The investor’s legal claims must be typical of those asserted on behalf of the class, and they must demonstrate their ability to adequately represent the interests of the entire class through experience, resources, and the absence of conflicts of interest.

It is crucial to note that both domestic and international investors who meet these criteria are eligible to seek appointment as the lead plaintiff in the class action lawsuit, as courts have consistently recognized the rights of non-U.S. investors in securities class actions.

What Are the Steps in the aTyr Pharma Class Action Lawsuit?

• Filing the Complaint: A lead plaintiff files a lawsuit on behalf of similarly affected shareholders, detailing the allegations against the company.

• Motion to Dismiss: Defendants typically file a motion to dismiss, arguing the complaint lacks sufficient claims.

• Discovery: If the motion to dismiss is denied, both parties gather evidence, documents, emails, and witness testimonies. This phase can be extensive.

• Motion for Class Certification: Plaintiffs request the court to certify the lawsuit as a class action. The court assesses factors like the number of plaintiffs, commonality of claims, typicality of claims, and the adequacy of the proposed class representation.

• Summary Judgment and Trial: Once the class is certified, the parties may file motions for summary judgment. If the case is not settled, it proceeds to trial, which is rare for securities class actions.

• Settlement Negotiations and Approval: Most cases are resolved through settlements, negotiated between the parties, often with the help of a mediator. The court must review and grant preliminary approval to ensure the settlement is fair, adequate, and reasonable.

• Class Notice: If the court grants preliminary approval, notice of the settlement is sent to all class members, often by mail, informing them about the terms and how to file a claim.

• Final Approval Hearing: The court conducts a final hearing to review any objections and grant final approval of the settlement.

• Claims Administration and Distribution: A court-appointed claims administrator manages the process of sending notices, processing claims from eligible class members, and distributing the settlement funds. The distribution is typically on a pro-rata basis based on recognized losses

What Is the Class Period in the aTyr Pharma Class Action Lawsuit?

In a securities class action, such as the aTyr Pharma  class action lawsuit:

• The class period refers to the specific time frame during which the alleged fraudulent activity occurred. It is the period in which the plaintiffs claim to have suffered financial losses due to misrepresentations or omissions made by the defendants.

• The class period is crucial in determining who can be included in the class and seek damages.

• It typically starts when the alleged frauaTyr Pharma  Class Action Lawsuit

• The class period usually ends when the alleged fraud is revealed to the public or when the plaintiffs file a lawsuit.

• The length of the class period can vary depending on the specific circumstances of each case.

What Are My Rights if I am a Class Member in the aTyr Pharma Class Action Lawsuit?

Investors facing losses due to the aTyr Pharma class action lawsuit  have several options available to them. Each option carries its own implications and potential outcomes.

Joining the Class Action

• One of the most straightforward options for investors is to join the aTyr Pharma class action lawsuit .

• By doing so, they can collectively pursue compensation for their losses without the need for individual litigation.

Filing an Individual Claim

• In certain situations, investors may opt to file individual claims instead of joining the aTyr Pharma lawsuit.

• This option may be appropriate for those who believe their losses are significant enough to warrant separate legal action.

Seeking Legal Advice

• Consulting with a legal professional experienced in securities law can provide investors with insights into their best course of action.

• Legal experts can help assess the merits of individual claims versus joining the class action.

The Role of Law Firms

• Law firms play a crucial role in the aTyr Pharma class action lawsuit.

• They provide the necessary legal experience and representation for investors seeking to recover their losses.

Selecting a Law Firm

• Investors have the option to choose a law firm that practices securities fraud cases.

• A reputable firm can offer valuable insights and increase the likelihood of a favorable outcome.

• If you suffered substantial losses and wish to serve as lead plaintiff of the aTyr Pharma class action lawsuit, or just have general questions about you rights as a shareholder, please contact attorney Timothy L. Miles of the Law Offices of Timothy L. Miles, at no cost, by calling 855/846-6529 or via e-mail at [email protected].